Page last updated: 2024-09-04

docetaxel anhydrous and indibulin

docetaxel anhydrous has been researched along with indibulin in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(indibulin)
Trials
(indibulin)
Recent Studies (post-2010) (indibulin)
12,1103,2166,92037220

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)indibulin (IC50)
Tubulin beta-2B chainBos taurus (cattle)0.25
Similar to alpha-tubulin isoform 1 Bos taurus (cattle)0.25
Similar to alpha-tubulin isoform 1 Bos taurus (cattle)0.25

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brett, ML; Colley, HE; Coole, SF; Danson, SJ; Dossetter, AG; Griffen, EJ; Harrison, J; Jackson, LV; Jennings, LR; Lockey, PM; Mason, DP; Muthana, M; Norman, D; Thompson, MJ; Tulasi, V; Williams, L; Wong, M1

Other Studies

1 other study(ies) available for docetaxel anhydrous and indibulin

ArticleYear
An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.
    Journal of medicinal chemistry, 2015, Dec-10, Volume: 58, Issue:23

    Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Proliferation; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Heterografts; Humans; Indoles; Male; Mice; Mice, Nude; Microtubules; Neoplasm Transplantation; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2015